US jurisdiction report: COVID-19’s impact on US patent practices
Pharmaceutical researchers across the country are desperately seeking an effective vaccine against COVID-19. Manufacturers that are seeking to serve the public interest by retooling their facilities to produce masks, gloves, and products needed to help combat the pandemic may face the risk of patent infringement liability.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
13 July 2020 The US Copyright Office has further extended the deadline for aspiring copyright owners who need to register their works electronically, by another 60 days, until September 8.
26 March 2020 Trademark filings at some of the world’s biggest IP offices have begun to fall, despite showing resilience late last week amid the COVID-19 pandemic.